MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-27-2025
Tiziana Life Sciences PLC Current Ratio 2011-2025 | TLSA
Annual Current Ratio Tiziana Life Sciences PLC
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.54 | 1.83 | 3.83 | 6.47 | 8.54 | 0.301 | 1.08 | 0.521 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.54 | 0.301 | 3.01 |
Quarterly Current Ratio Tiziana Life Sciences PLC
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 6.47 | - | - | - | 8.54 | - | - | - | 0.3 | - | - | - | 1.08 | - | - | - | 0.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.54 | 0.3 | 3.38 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aptevo Therapeutics
APVO
|
1.44 | $ 0.58 | -3.71 % | $ 160 K |  USA |
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
3.4 | $ 3.03 | - | $ 234 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.15 | -0.63 % | $ 7.58 B |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
2.2 | $ 1.91 | 14.49 % | $ 487 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | USA |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
3.71 | $ 1.11 | -2.63 % | $ 6.05 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
0.918 | $ 211.38 | 1.15 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
BioVie
BIVI
|
8.46 | $ 1.17 | -3.31 % | $ 1.73 M | USA |
 |
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
2.38 | - | 3.77 % | $ 22.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 0.17 | -18.42 % | $ 370 M |  Israel |
 |
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
7.22 | $ 95.19 | 0.71 % | $ 27.2 B | Germany |
 |
Catalyst Biosciences
CBIO
|
3.06 | $ 12.36 | 0.08 % | $ 814 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.87 | $ 26.84 | -1.03 % | $ 1.3 B | USA |
 |
BeiGene, Ltd.
BGNE
|
2.29 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
4.13 | - | -10.95 % | $ 876 K | USA |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 9.52 | -0.37 % | $ 140 M | USA |
 |
Certara
CERT
|
3.05 | $ 8.86 | -0.39 % | $ 1.42 B | USA |
 |
bluebird bio
BLUE
|
1.46 | - | - | $ 546 M | USA |
 |
Cellectis S.A.
CLLS
|
1.52 | $ 4.9 | 3.16 % | $ 116 M | France |
 |
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
2.08 | $ 580.39 | -0.59 % | $ 44 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.57 | 4.7 % | $ 16.1 M | USA |
 |
AstraZeneca PLC
AZN
|
1.65 | $ 92.75 | -0.16 % | $ 96.9 B | Britain |
 |
ChromaDex Corporation
CDXC
|
3.08 | - | -0.88 % | $ 598 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
2.14 | $ 9.26 | 1.93 % | $ 1.49 B | Britain |
 |
Celldex Therapeutics
CLDX
|
17.5 | $ 26.14 | -0.98 % | $ 1.68 M | USA |